Literature DB >> 30279168

Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.

Larissa Lamertz1, Franziska Rummel1, Robin Polz1, Paul Baran1, Selina Hansen1, Georg H Waetzig2, Jens M Moll1, Doreen M Floss1, Jürgen Scheller3.   

Abstract

Interleukin-6 (IL-6) is a proinflammatory cytokine of the IL-6 family, members of which signal through a complex of a cytokine-specific receptor and the signal-transducing subunit gp130. The interaction of IL-6 with the membrane-bound IL-6 receptor (IL-6R) and gp130 stimulates "classic signaling," whereas the binding of IL-6 and a soluble version of the IL-6R to gp130 stimulates "trans-signaling." Alternatively, "cluster signaling" occurs when membrane-bound IL-6:IL-6R complexes on transmitter cells activate gp130 receptors on neighboring receiver cells. The soluble form of gp130 (sgp130) is a selective trans-signaling inhibitor, but it does not affect classic signaling. We demonstrated that the interaction of soluble gp130 with natural and synthetic membrane-bound IL-6:IL-6R complexes inhibited IL-6 cluster signaling. Similarly, IL-11 cluster signaling through the IL-11R to gp130 was also inhibited by soluble gp130. However, autocrine classic and trans-signaling was not inhibited by extracellular inhibitors such as sgp130 or gp130 antibodies. Together, our results suggest that autocrine IL-6 signaling may occur intracellularly.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30279168     DOI: 10.1126/scisignal.aar7388

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  21 in total

1.  Small Noncoding RNA (sncRNA1) within the Latency-Associated Transcript Modulates Herpes Simplex Virus 1 Virulence and the Host Immune Response during Acute but Not Latent Infection.

Authors:  Kati Tormanen; Harry H Matundan; Shaohui Wang; Ujjaldeep Jaggi; Kevin R Mott; Homayon Ghiasi
Journal:  J Virol       Date:  2022-03-07       Impact factor: 6.549

Review 2.  The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Authors:  Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

3.  Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC).

Authors:  Gigja Gudbrandsdottir; Helene H Aarstad; Leif Bostad; Karin M Hjelle; Hans J Aarstad; Øystein Bruserud; Tor Henrik Anderson Tvedt; Christian Beisland
Journal:  Cancer Immunol Immunother       Date:  2020-07-03       Impact factor: 6.968

Review 4.  The Role of gp130 Cytokines in Tuberculosis.

Authors:  Kristina Ritter; Jasmin Rousseau; Christoph Hölscher
Journal:  Cells       Date:  2020-12-15       Impact factor: 6.600

Review 5.  Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.

Authors:  Negar Moradian; Mahdi Gouravani; Mohammad Amin Salehi; Arash Heidari; Melika Shafeghat; Michael R Hamblin; Nima Rezaei
Journal:  Eur Cytokine Netw       Date:  2020-09-01       Impact factor: 3.450

Review 6.  Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).

Authors:  Amir Hossein Norooznezhad; Kamran Mansouri
Journal:  Microvasc Res       Date:  2021-05-19       Impact factor: 3.514

Review 7.  New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.

Authors:  Maria D Giraldez; David Carneros; Christoph Garbers; Stefan Rose-John; Matilde Bustos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-01       Impact factor: 46.802

Review 8.  Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.

Authors:  Riley D Metcalfe; Tracy L Putoczki; Michael D W Griffin
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

9.  Global Transcriptional Profiling Reveals Novel Autocrine Functions of Interleukin 6 in Human Vascular Endothelial Cells.

Authors:  Liza U Ljungberg; Mulugeta M Zegeye; Caroline Kardeby; Knut Fälker; Dirk Repsilber; Allan Sirsjö
Journal:  Mediators Inflamm       Date:  2020-04-28       Impact factor: 4.711

10.  Associations between the IL-6-neutralizing sIL-6R-sgp130 buffer system and coronary artery disease in postmenopausal women.

Authors:  Man Zhou; Wen Dai; Yan Cui; Huan Liu; Yan Li
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.